Zobrazeno 31 - 40
of 1 317
pro vyhledávání: ''
Autor:
Miguel Gil-Gil, José A. García-Sáenz, E Dalmau Portulas, Elena García-Martínez, Nuria Ribelles, A. Santaballa Bertran, E. Martínez de Dueñas, I Alvarez-Lopez, Susana Bezares
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Clinical & Translational Oncology
Universidad de Barcelona
Clinical & Translational Oncology
PurposeHormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic approach that takes into account multiple factors, with treatment being based on anti-estrogen hormo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b63a263cb82f360402dddafab187eefb
http://hdl.handle.net/2445/174389
http://hdl.handle.net/2445/174389
Autor:
Udo Bavendiek, Robert Geffers, Maximilian Brandes, Timon Seeger, Arnold Ganser, Michael Heuser, Joerg Heineke, David John, Brigitte Schlegelberger, Piroska Klement, Razif Gabdoulline, Abel Martin Garrido, Felicitas Thol, Johann Bauersachs, Gudrun Göhring, Amir Shirvani, Badder Kattih, Anuhar Chaturvedi, Alessandro Liebich
Publikováno v:
Leukemia
Clonal hematopoiesis of indeterminate potential (CHIP) is linked to leukemia gene mutations and associates with an increased risk for coronary artery disease and poor prognosis in ischemic cardiomyopathy. Two recurrently mutated genes in CHIP and adu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2024100c560082a18b7bc28f0645166
https://hdl.handle.net/10033/622512
https://hdl.handle.net/10033/622512
Autor:
Hisashi Motomura, Wataru Goto, Shinichiro Kashiwagi, Yuka Asano, Shuhei Tomita, Koji Takada, Masahiko Ohsawa, Katsuyuki Takahashi, Kosei Hirakawa, Masaichi Ohira, Tsutomu Takashima, Takaharu Hatano
Publikováno v:
British Journal of Cancer
Background Immune responses in a tumour microenvironment can be evaluated by analysing tumour-infiltrating lymphocyte (TIL) density; this has been verified in the clinical setting. Although there are many reports on TIL density in primary tumours, li
Publikováno v:
British Journal of Cancer
Background Sorafenib is the current standard of care for patients with advanced hepatocellular carcinoma (aHCC) and has been shown to improve survival by about 3 months compared to placebo. However, survival varies widely from under three months to o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13be75dabcfd7569fa76da2b074a6f30
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-12 (2019)
BMC Cancer
BMC Cancer
Background The literature on sexual orientation disclosure is arguably one of the most developed in the field of lesbian, gay and bisexual (LGB) people in healthcare in English speaking countries however, relatively little research has been conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2347c5eda80143ec18b2f4c3d344bc4
https://www.dora.dmu.ac.uk/handle/2086/18225
https://www.dora.dmu.ac.uk/handle/2086/18225
Autor:
Susumu Inamoto, Yoshiro Itatani, Gen Nishikawa, Jun Nakagawa, Rei Mizuno, Kenji Kawada, Yoshiharu Sakai, Ryotaro Ogawa, Kosuke Toda
Publikováno v:
Cell Death and Disease, Vol 10, Iss 4, Pp 1-13 (2019)
Cell Death & Disease
Cell Death & Disease
Mesenchymal stem cells (MSCs) are recruited from BM to the stroma of developing tumors, where they serve as critical components of the tumor microenvironment by secreting growth factors, cytokines, and chemokines. The role of MSCs in colorectal cance
Autor:
Chris Twelves, Matthew Guo, Larisa Reyderman, Ishtiaq Husain Zubairi, R. Morrison, Nicola Cresti, Claudio Savulsky, Alan Anthoney, Vladimir Semiglazov, Ruth Plummer, T.R. Jeffry Evans, Constanta Timcheva
Publikováno v:
British Journal of Cancer
Background: \ud Capecitabine and eribulin are widely used as single agents in metastatic breast cancer (MBC) and have nonoverlapping toxicities.\ud \ud Methods: \ud In phase 1b (dose escalation), patients with advanced, treatment-refractory, solid tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97bccd2276eddef510b3a7b2fcc67aa0
https://eprints.whiterose.ac.uk/148290/1/s41416-018-0366-5.pdf
https://eprints.whiterose.ac.uk/148290/1/s41416-018-0366-5.pdf
Autor:
Haase, D, Stevenson, KE, Neuberg, D, Maciejewski, JP, Nazha, A, Sekeres, MA, Ebert, BL, Garcia-Manero, G, Haferlach, C, Haferlach, T, Kern, W, Ogawa, S, Nagata, Y, Yoshida, K, Graubert, TA, Walter, MJ, List, AF, Komrokji, RS, Padron, E, Sallman, D, Papaemmanuil, E, Campbell, PJ, Savona, MR, Seegmiller, A, Adès, L, Fenaux, P, Shih, L-Y, Bowen, D, Groves, MJ, Tauro, S, Fontenay, M, Kosmider, O, Bar-Natan, M, Steensma, D, Stone, R, Heuser, M, Thol, F, Cazzola, M, Malcovati, L, Karsan, A, Ganster, C, Hellström-Lindberg, E, Boultwood, J, Pellagatti, A, Santini, V, Quek, L, Vyas, P, Tüchler, H, Greenberg, PL, Bejar, R, Committee, International Working Group For Mds Molecular Prognostic
Publikováno v:
Leukemia
Leukemia, vol 33, iss 7
Leukemia, vol 33, iss 7
Risk stratification is critical in the care of patients with myelodysplastic syndromes (MDS). Approximately 10% have a complex karyotype (CK), defined as more than two cytogenetic abnormalities, which is a highly adverse prognostic marker. However, C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d49797d5f17dd3791db8ac57149af6e
https://ora.ox.ac.uk/objects/uuid:e9f86a5f-8ced-4bb7-944f-fa27fc2c2541
https://ora.ox.ac.uk/objects/uuid:e9f86a5f-8ced-4bb7-944f-fa27fc2c2541
Autor:
Lorraine Hughes, Glen J. Weiss, Javier de Castro Carpeño, Wu Chou Su, Dmitri Bobilev, Monica M. Mita, Rafal Dziadziuszko, Sharon Lu, Chia-Chi Lin, Hendrik Tobias Arkenau, Jasgit C. Sachdev, Zhi Yi Zhang, Jian Chan
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
British Journal of Cancer
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
instname
British Journal of Cancer
Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Anaplastic lymphoma kinase (ALK) gene rearrangements are oncogenic drivers in non-small-cell lung cancer (NSCLC). TSR-011 is a dual ALK and tropomyosin-related kinase (TRK) inhibitor, active against ALK inhibitor resistant tumours in preclinical stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5822b104b4588aecd000061a4f2c4c61
http://hdl.handle.net/10486/691907
http://hdl.handle.net/10486/691907
Autor:
Judy Garber, Clara Li, Kevin S. Hughes, Suzanne B. Coopey, Francisco Acevedo, Amy S. Colwell, Danielle Braun, Regina Barzilay, Adam Yala, Tari A. King, Barbara L. Smith, Anthony J. Guidi, Curtis L. Cetrulo, Rong Tang, V. Diego Armengol, Zhengyi Deng
Publikováno v:
Other repository
© 2018, Springer Science+Business Media, LLC, part of Springer Nature. Purpose: Mammoplasty removes random samples of breast tissue from asymptomatic women providing a unique method for evaluating background prevalence of breast pathology in normal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e84cacd853968a680255161596c752
https://hdl.handle.net/1721.1/134753
https://hdl.handle.net/1721.1/134753